Sanofi (SNYNF)
86.67
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Sanofi Enterprise Value : 123.69B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 123.69B |
| June 08, 2026 | 123.69B |
| June 05, 2026 | 125.06B |
| June 04, 2026 | 123.62B |
| June 03, 2026 | 123.61B |
| June 02, 2026 | 120.13B |
| June 01, 2026 | 123.71B |
| May 29, 2026 | 123.71B |
| May 28, 2026 | 123.71B |
| May 27, 2026 | 112.98B |
| May 26, 2026 | 115.10B |
| May 22, 2026 | 114.93B |
| May 21, 2026 | 116.47B |
| May 20, 2026 | 115.29B |
| May 19, 2026 | 111.21B |
| May 18, 2026 | 111.16B |
| May 15, 2026 | 112.47B |
| May 14, 2026 | 108.99B |
| May 13, 2026 | 110.76B |
| May 12, 2026 | 112.76B |
| May 11, 2026 | 110.84B |
| May 08, 2026 | 109.86B |
| May 07, 2026 | 112.37B |
| May 06, 2026 | 112.37B |
| May 05, 2026 | 111.24B |
| Date | Value |
|---|---|
| May 04, 2026 | 116.11B |
| May 01, 2026 | 123.83B |
| April 30, 2026 | 118.96B |
| April 29, 2026 | 119.26B |
| April 28, 2026 | 119.62B |
| April 27, 2026 | 123.10B |
| April 24, 2026 | 119.96B |
| April 23, 2026 | 119.96B |
| April 22, 2026 | 119.96B |
| April 21, 2026 | 124.71B |
| April 20, 2026 | 124.71B |
| April 17, 2026 | 122.81B |
| April 16, 2026 | 122.81B |
| April 15, 2026 | 122.81B |
| April 14, 2026 | 122.20B |
| April 13, 2026 | 122.20B |
| April 10, 2026 | 121.65B |
| April 09, 2026 | 121.65B |
| April 08, 2026 | 121.64B |
| April 07, 2026 | 123.34B |
| April 06, 2026 | 123.34B |
| April 02, 2026 | 123.34B |
| April 01, 2026 | 122.22B |
| March 31, 2026 | 121.55B |
| March 30, 2026 | 121.56B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AstraZeneca PLC | 595.23B |
| Pfizer Inc. | 198.15B |
| GSK Plc | 123.03B |
| Merck & Co., Inc. | 338.77B |
| Johnson & Johnson | 603.30B |
Enterprise Value Related Metrics
| Earnings Yield | 5.51% |
| Operating Earnings Yield | 12.19% |
| Normalized Earnings Yield | 8.200 |